Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Open in API
Filings indexed 1,473 across all filing types
Latest filing 2020-06-15 Declaration of Voting R…
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 15, 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on June 15, 2020. It details the voting outcomes on various resolutions including receipt of audited financial statements, re-election of directors, appointment of auditors, and share issuance mandates. The document does not contain the full AGM materials or presentations, nor is it a full annual report or financial statement. It is specifically reporting the official voting results from the AGM. The document length is 4229 characters, which is consistent with a typical voting results announcement rather than a full report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-06-15 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 12 JUNE 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on 12 June 2020. It details the voting outcomes on various resolutions including adoption of audited financial statements, re-election of directors, re-appointment of auditors, and granting mandates to directors. The document does not contain the full AGM materials or presentations but reports the official voting results. The document length is 3790 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-06-12 English
Land Parcel No. G11207-1, Pingshan New Area, Longgang, Shenzhen City Urban Renewal Project Developers' Right and Interest Restructuring
Regulatory Filings Classification · 95% confidence The document is an announcement related to a specific urban renewal project involving restructuring of developers' rights and interests. It references previous announcements and circulars, details cooperative agreements, and mentions future supplementary agreements to be signed. The content is focused on corporate developments and project cooperation rather than financial results, management changes, or regulatory filings. The document is an announcement of a corporate development related to a project, not a financial report or management change notice. It is not a report publication announcement since it contains substantive information about the restructuring and agreements. The document fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories like M&A, Board changes, or Capital updates.
2020-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/5/2020 and submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. It includes confirmations by the company secretary regarding compliance with listing rules and legal requirements. The content focuses on share capital changes and securities movements rather than financial performance, management discussion, or earnings. It is a regulatory disclosure about share capital movements and securities issued, typical of a Major Shareholding Notification or similar capital movement report. Given the detailed share capital movements and confirmations, the best fitting category is Share Issue/Capital Change (SHA). The document is substantive and not merely an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2020-06-02 English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 May 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/5/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document length is 13,528 characters, indicating a detailed report rather than a brief announcement. Given the nature of the content, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2020-06-01 English
CLARIFICATION ANNOUNCEMENT - FORM OF PROXY FOR THE 2020 ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a clarification announcement related to the form of proxy for the 2020 Annual General Meeting (AGM) of Ascletis Pharma Inc. It specifically addresses a correction to a resolution in the proxy form for the AGM. The document does not contain financial data, results, or detailed reports but is an announcement clarifying proxy voting materials for the AGM. According to the filing definitions, materials related to the AGM, including proxy forms and clarifications thereof, fall under AGM Information (AGM-R). The document length is short and it is clearly an announcement related to the AGM materials, not the AGM results or the full report itself.
2020-05-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.